©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Orthop. Aug 18, 2022; 13(8): 703-713
Published online Aug 18, 2022. doi: 10.5312/wjo.v13.i8.703
Published online Aug 18, 2022. doi: 10.5312/wjo.v13.i8.703
Fluctuation of visual analog scale pain scores and opioid consumption before and after total hip arthroplasty
Vivek Singh, Alex Tang, Thomas Bieganowski, Utkarsh Anil, William Macaulay, Ran Schwarzkopf, Roy I Davidovitch, Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, New York, NY 10010, United States
Author contributions: Singh V, Tang A, and Bieganowski T write the manuscript; Singh V collected the data; Singh V and Anil U did the analysis; Macaulay W did the edits. Schwarzkopf R and Davidovitch RI are responsible for conceptualization and manuscript editing.
Institutional review board statement: The present study retrospectively analysed de-identified data for institutional quality improvement initiative and was therefore exempted from human-subjects review by our Institutional Review Board.
Informed consent statement: Informed consent was not needed for this study. This was a quality improvement initiative at our institution.
Conflict-of-interest statement: Singh V, Tang A, Bieganowski T and Anil U have nothing to disclose. Macaulay W holds stock options in OrthoAlign. Schwarzkopf R is a paid consultant for Smith & Nephew and Intellijoint. He also has stock options in Gauss Surgical outside the submitted work. Davidovitch RI is a paid consultant for Radlink, Schaerer Medical, Exactech, and Medtronics.
Data sharing statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Corresponding author: Vivek Singh, MD, Doctor, Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, 301 E 17th Street, New York, NY 10010, United States. vivek.singh@nyulangone.org
Received: October 1, 2021
Peer-review started: October 1, 2021
First decision: January 11, 2022
Revised: January 28, 2022
Accepted: July 22, 2022
Article in press: July 22, 2022
Published online: August 18, 2022
Processing time: 319 Days and 10.4 Hours
Peer-review started: October 1, 2021
First decision: January 11, 2022
Revised: January 28, 2022
Accepted: July 22, 2022
Article in press: July 22, 2022
Published online: August 18, 2022
Processing time: 319 Days and 10.4 Hours
Core Tip
Core Tip: Our results should be used to appropriately guide opioid prescribing patterns and set patient expectations regarding expected pain management following total hip arthroplasty (THA). This will not only give patients a baseline to reference during their recovery but also limit redundant billing expenses related to unnecessary prescription of medication and avoidable outpatient visits due to post-operative pain. However, without further research that considers other patient factors that influence pain severity, our understanding of the independent impact of pain on opioid consumption after THA remains uncertain.